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Abstract: Embryogenesis is regulated by genetic programs that are dynamically executed in a stereotypic
manner, and deciphering these molecular mechanisms requires the ability to control embryonic gene function
with similar spatial and temporal precision. Chemical technologies can enable such genetic manipulations,
as exempliﬁed by the use of caged morpholino (cMO) oligonucleotides to inactivate genes in zebraﬁsh
and other optically transparent organisms with spatiotemporal control. Here we report optimized methods
for the design and synthesis of hairpin cMOs incorporating a dimethoxynitrobenzyl (DMNB)-based
bifunctional linker that permits cMO assembly in only three steps from commercially available reagents.
Using this simpliﬁed procedure, we have systematically prepared cMOs with differing structural conﬁgurations
and investigated how the in vitro thermodynamic properties of these reagents correlate with their in vivo
activities. Through these studies, we have established general principles for cMO design and successful-
ly applied them to several developmental genes. Our optimized synthetic and design methodologies have
also enabled us to prepare a next-generation cMO that contains a bromohydroxyquinoline (BHQ)-based
linker for two-photon uncaging. Collectively, these advances establish the generality of cMO technologies
and will facilitate the application of these chemical probes in vivo for functional genomic studies.
Introduction
Embryonic development relies upon the precise control of
genetic programs to create complex tissues and organs. Mu-
tagenesis screens and the sequencing of multiple genomes have
revealed an extensive list of patterning genes, many of which
are expressed in a tissue-speciﬁc manner within the developing
embryo. One of the remaining challenges in developmental
biology is to understand how these genes act in space and time
to modulate cell proliferation, migration, and differentiation in
a stereotypic manner. Toward that goal, several genetic ap-
proaches for conditional gene regulation have been developed,
such as the FLP/FRT, Cre/Lox, and Tet-ON/Tet-OFF systems,
and these technologies have provided key insights into the
molecular mechanisms that underlie tissue patterning and
function.
1
Chemical technologies are also required for surmounting this
challenge, especially in biological systems for which reverse-
genetic methods are limited. For example, the zebraﬁsh is ideally
suited for visualizing vertebrate ontogeny, since its embryos
and larvae are optically transparent and develop rapidly ex
utero.
2 However, methods for regulating endogenous gene
function in zebraﬁsh are underdeveloped relative to those for
other model organisms; targeted gene knockouts by homologous
recombination and inducible RNA interference technologies
have not yet been achieved.
3 In lieu of these approaches,
synthetic oligonucleotides such as morpholinos (MOs) and
negatively charged peptide nucleic acids (ncPNAs) have been
employed as antisense reagents in zebraﬁsh embryos (Figure
1).
4,5 MO nucleoside analogues display DNA bases from a
morpholine ring system and are connected by a phosphorodia-
midate backbone, while ncPNA monomers are composed of
alternating trans-4-hydroxy-L-proline/phosphonate polyamides,
each functionalized with a DNA base. Because of these non-
natural structures, both MOs and ncPNAs are resistant to
nucleases and persist for up to 4 days in zebraﬁsh embryos.
Thus, when MO or ncPNA oligomers are injected into zebraﬁsh
prior to the eight-cell stage, they become uniformly distributed
throughout the embryo and constitutively block either RNA
splicing or translation, depending on the targeted sequence. In
the case of MOs, oligomers containing 25 bases are typically
used, while ncPNA oligomers are limited to 18 bases. Unlike
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While MOs and ncPNAs have been used to interrogate gene
function in zebraﬁsh and other model organisms, the utility of
these reagents is restricted by their constitutive activity. Gene
expression is inhibited immediately after introduction of the
antisense oligomers, and because they are typically injected into
early-stage embryos, this blockade persists in most, if not all,
cell lineages. Conventional MOs and ncPNAs therefore are less
effective for studying genes that are required for embryonic
survival and/or have pleiotropic functions at different develop-
mental stages or in distinct tissues. To overcome this limitation,
we recently developed caged morpholinos (cMOs) that can be
activated by light, taking advantage of the transparency of
zebraﬁsh embryos and larvae.
7 This was achieved by tethering
a complementary MO-derived inhibitor to the 25-base targeting
sequence through a dimethoxynitrobenzyl (DMNB)-based pho-
tocleavable linker, resulting in a hairpin structure (Figure 2).
The intramolecular duplex suppresses binding of the targeting
sequence to its complementary RNA, and the stem-loop
conﬁguration is signiﬁcantly less active in vivo. After linker
cleavage with 360-nm light, the inhibitor dissociates from the
25-base MO, allowing the antisense reagent to prevent splicing
or translation of its RNA target. Similar caging strategies have
previously been described for regulating DNA duplex formation
and RNA function in vitro,
8-11 and this general approach differs
from complementary oligonucleotide-caging technologies that
target individual nucleoside bases,
12,13 the phosphate back-
bone,
14-16 or oligonucleotide termini.
17
As a proof of principle, we ﬁrst used this methodology to
conditionally silence a T-box transcription factor called no tail-a
(ntla), which is required for the differentiation of axial
mesodermal cells into a transient, chordate-speciﬁc organ called
the notochord.
18,19 Embryos lacking ntla function exhibit clear
morphological phenotypes in a cell-autonomous manner, pro-
viding an ideal system for evaluating the efﬁcacy of cMOs in
vivo. In particular, ntla mutants or morphants (as MO-injected
embryos are commonly called) lack a notochord, are posteriorly
truncated, and exhibit U-shaped rather than V-shaped somites.
The latter defect is collateral to notochord ablation, since the
notochord secretes morphogens to pattern the ﬂanking myo-
tome.
20 Mutants or morphants lacking ntla function also exhibit
an ectopic medial ﬂoor plate, a ventral region of the developing
spinal cord, and it is believed that ntla acts as a transcriptional
switch between notochord and medial ﬂoor plate cell fates.
18,21
By varying the developmental stage at which we activated the
ntla cMO, we found that this transcription factor is required
not only for speciﬁcation of the mesoderm toward notochord
cell fates but also for the maturation of notochord progenitors
into a highly vacuolated tissue.
7 We also demonstrated our
ability to silence ntla expression in a subset of mesodermal cells
by activating the ntla cMO in a spatially restricted manner,
selectively redirecting these populations to differentiate into
medial ﬂoor plate cells. A similar caging approach has been
applied to ncPNAs targeting the chordin (chd) and dharma (dha)
genes, although the use of these photoactivatable ncPNA
hairpins to spatially control gene expression has not been
reported to date.
22
While our results established the general principle of using
caged oligonucleotides to conditionally regulate in vivo gene
expression, there are limitations associated with these initial
investigations. First, our previous studies required preparation
of the inhibitory oligomer and its appendant DMNB linker
through solid-phase chemistries, since conventional MOs ame-
nable to terminal hydroxyl modiﬁcations were not commercially
available at that time. These procedures are laborious and time-
consuming, hindering the synthesis and evaluation of other
cMOs. Second, guidelines for the design of other hairpin cMOs
were not evident from our ﬁndings, as only one inhibitory
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Figure 1. Structures of DNA, MO, and ncPNA oligonucleotides.
Figure 2. Schematic representation of the hairpin cMO strategy.
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general rules for caged oligonucleotide design be derived from
the ncPNA study, which limited its analysis to single chd- and
dha-targeting reagents with divergent structures and dosages.
22
Finally, the reliance of both classes of caged oligonucleotides
on nitrobenzyl-based chromophores restricts their use to single-
photon irradiation with UV light, which can induce DNA lesions
and has limited spatial resolution. Photoactivatable MOs and
ncPNAs that are compatible with two-photon excitation could
be activated with less coincident damage, deeper tissue penetra-
tion, and greater spatial precision.
23
We report herein our resolution of these issues through the
development of new hairpin cMOs. We have designed and
synthesized a DMNB-based bifunctional linker that can be used
to conjugate the targeting MO and its complementary inhibitor
in only three steps, starting with appropriately functionalized
MO oligomers that are now commercially available. We have
utilized this optimized synthetic route to prepare a series of ntla-
targeting cMOs with differing structural conﬁgurations, thereby
allowing us to systematically analyze how the in vivo efﬁcacy
of these reagents correlates with their biophysical properties.
Through these studies, we have demonstrated that cMO activity
in vivo can be modeled in simpliﬁed thermodynamic terms, and
we have established guidelines for the preparation of other
cMOs. These design criteria have enabled us to prepare
photoactivatable reagents targeting the zebraﬁsh genes heart of
glass (heg),
24 ﬂoating head (ﬂh),
25 and endothelial-speciﬁc
Variant gene 2 (etV2).
26 We have further demonstrated the
versatility of this approach by replacing the DMNB chro-
mophore with a bromohydroxyquinoline (BHQ) group, which
has a signiﬁcantly greater cross section for two-photon
excitation.
27,28 These studies represent the ﬁrst comprehensive
analysis of the structure and in vivo function of hairpin-caged
oligonucleotides, providing a foundation upon which future
chemical technologies for conditional gene regulation can be
based.
Results and Discussion
Development of a DMNB-Based Bifunctional Linker for
Hairpin cMO Synthesis. Since our current cMO design involves
the conjugation of a targeting MO to a complementary inhibitor,
modiﬁcations of the hydroxyl- and amine-functionalized termini
of each oligomer (designated as the 5′ and 3′ ends, respectively)
are necessary. At the time of our initial studies, MOs function-
alized with 3′ primary amines were commercially available, but
5′-amine oligomers were not. We therefore prepared an inhibi-
tory oligonucleotide conjugated at its 5′ end to a photocleavable
linker (1; Chart 1) using solid-phase chemistry. This required
the synthesis of all four MO bases, a linker-modiﬁed MO
monomer, and multiple rounds of solid-phase coupling (Scheme
S1 in the Supporting Information).
7 Addition of the linker-
functionalized inhibitor to the targeting MO was then achieved
through a Cu(I)-catalyzed Huisgen 1,3-dipolar cycloaddition
(“click” chemistry
29). Although this approach is ultimately
effective, its utilization of time-consuming and labor-intensive
procedures hinders the application of hairpin cMOs to other
developmental genes.
To streamline the synthesis of cMOs, we developed a new
strategy that takes advantage of the recent commercial avail-
ability of 5′-amine MOs. Our goal was to prepare a bifunctional
linker that contains the DMNB chromophore, an N-hydroxy-
succinimide ester for amine conjugation, and a terminal alkyne
for azide cycloaddition through “click” chemistry. With ap-
propriately functionalized targeting and inhibitory MOs, the
cMO could then be assembled in three steps. We ﬁrst synthe-
sized the bifunctional, photocleavable cross-linker 2a (Chart 1
and Scheme 1). The DMNB amino alcohol 3a
7 was selectively
acylated with methyl adipoyl chloride to give amide 4a, which
was then activated by 1,1′-carbonyldiimidazole and coupled with
6-amino-N-(prop-2-ynyl)hexanamide
30 to provide the propargyl
(23) Furuta, T.; Wang, S. S.; Dantzker, J. L.; Dore, T. M.; Bybee, W. J.;
Callaway, E. M.; Denk, W.; Tsien, R. Y. Proc. Natl. Acad. Sci. U.S.A.
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1995, 378, 150–157.
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Soc. 2006, 128, 4267–4276.
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Chem., Int. Ed. 2002, 41, 2596–2599.
(30) Bonnet, D.; Ilien, B.; Galzi, J. L.; Riche, S.; Antheaune, C.; Hibert,
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Chart 1. Chemical Structures of Linker-Conjugated Inhibitor 1
Obtained through Solid-Phase Chemistry and Bifunctional Linker
2a for Solution-Phase Chemistry
Scheme 1. Synthesis of Bifunctional Linkers 2a and 2b
a
a Reagents and conditions: (a) methyl adipoyl chloride, DIPEA, CH2Cl2,
86%; (b) 1,1′-carbonyldiimidazole, DMF, 88%; (c) 6-amino-N-(prop-2-
ynyl)hexanamide, DIPEA, CH2Cl2, 64%; (d) 2 M NaOH(aq), THF, MeOH,
93%; (e) disuccinimidyl carbonate, pyridine, acetonitrile, 75%. Yields are
those obtained for the DMNB derivatives.
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the corresponding acid with disuccinimidyl carbonate then
yielded linker 2a, which is orthogonally reactive with azides
and amines.
To prepare a ntla cMO through this synthetic approach, a
targeting MO (5′-GACTTGAGGCAGACATATTTCCGAT-3′)
was functionalized with 3-azidopropionic acid succinimidyl ester
to yield the azide derivative 6 (Scheme 2). Linker 2a was then
reacted with the commercially available 5′-amine- and 3′-
ﬂuorescein-functionalized MO (5′-TATGTCTGCC-3′)i n0 . 1M
sodium borate buffer (pH 8.5) to generate linker-derivatized
inhibitory oligomer 7a, and the two MO oligomers were coupled
through “click” chemistry in 0.1 M potassium phosphate buffer
(pH 8) containing sodium ascorbate, CuI, and tris[(1-benzyl-
1H-1,2,3-triazol-4-yl)methyl]amine (TBTA). Puriﬁcation of the
ﬁnal product by ion-exchange HPLC using NaClO4 as the eluent
then yielded the ntla cMO 8a.
To evaluate the in vivo efﬁcacy of this reagent, we next
injected 8a into wild-type zebraﬁsh embryos at the one-cell stage
and globally irradiated approximately half of the embryos with
360-nm light (13 mW/cm2) for 10 s at 3 h post fertilization
(hpf). The remaining embryos were cultured in the dark as
negative controls, and the resulting phenotypes at 1 day post
fertilization (dpf) were then scored. As we have described
previously, ntla loss-of-function phenotypes can be categorized
into four classes according to their severity: class I ) a fully
penetrant ntla mutant phenotype characterized by no notochord,
U-shaped somites, and a lack of posterior structures; class II )
no notochord, U-shaped somites, and some posterior somites;
class III ) incompletely vacuolated notochord, V-shaped
somites, and a shortened anterior-posterior axis; and class IV
) wild-type phenotype (Figure 3A).
7 These phenotypes can be
recapitulated by injecting early-stage embryos with varying
doses of the conventional ntla MO, and classes I-IV correspond
respectively to doses of g115, 57, 28, and e14 fmol/embryo
(Figure 3B). Since the class I phenotype can be achieved with
ntla MO levels g115 fmol/embryo, we utilized 8a at this
minimum dose in this experiment. To our surprise, 8a induced
class-II and class-III phenotypes in the absence of irradiation
Figure 3. Conventional and caged MOs targeting the ntla gene and
classiﬁcation of ntla mutant phenotypes. (A) Classiﬁcation of ntla mutant
phenotypes according to morphological cues. Somitic (s), medial ﬂoor plate
(mfp), notochord (nc), and yolk extension (ye) tissues are labeled. Scale
bars: left panels, 200 µm; right panels, 50 µm. Bright-ﬁeld (left) and
differential interference contrast (right) images of 1 dpf embryos are shown.
(B) Distribution of phenotypes according to the dose (per embryo) of a
conventional ntla MO. (C) Distribution of phenotypes for ntla cMO 8a at
a dose of 115 fmol/embryo with and without photoactivation.
Scheme 2. Simpliﬁed Strategy for cMO Synthesis
a
a Reagents and conditions: (a) 2,5-dioxopyrrolidin-1-yl 3-azidopropanoate, 0.1 M sodium borate (pH 8.5)/3:1 (v/v) DMSO, 98%; (b) bifunctional DMNB
linker 2a or 2b, 0.1 M sodium borate (pH 8.5)/DMSO 6:1 (v/v), 70-90%; (c) sodium ascorbate, TBTA, CuI, 0.1 M potassium phosphate (pH 8.0), DMSO,
10-25% after HPLC. The ntla cMOs 8a-h, 8a′, and 8e′ were prepared through this synthetic route, using the ntla-targeting MO (5′-GACTTGAGGCA-
GACATATTTCCGAT-5′) and inhibitory MOs having various lengths and sequences (Table 1).
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prior to uncaging.
7 Since the targeting and inhibitory MOs used
in this reagent are identical to those in our previous study, this
difference in caging efﬁciency must reﬂect changes in the linker
structure.
Gene-Silencing Activities and Biophysical Properties of
Hairpin ntla cMOs. Reasoning that the hairpin cMO efﬁcacy
depends on the interplay between inhibitor length, stem-loop
conﬁguration, and linker formats, we used linker 2a to prepare
ntla cMOs with differing structures (8a-h; Figure 4 and Table
1). In particular, we varied the length of the inhibitory MO (10,
12, 14, and 16 bases) and evaluated both “blunt” and “staggered”
stem-loops. Each ntla cMO was synthesized, puriﬁed by ion-
exchange HPLC, injected into one-cell-stage zebraﬁsh embryos,
and photoactivated as before, except that a dose of 230 fmol/
embryo was evaluated in each case. This higher cMO concen-
tration was used for these studies to maximize our ability to
identify caged conﬁgurations with minimum basal activity.
The resulting phenotypes conﬁrmed that hairpin cMO activity
varies signiﬁcantly with inhibitor length and stem-loop struc-
ture. Within a stem-loop conﬁguration, increasing the number
of bases in the inhibitory oligomer decreased the cMO activity
under both basal and photoactivated conditions. The “blunt”
and “staggered” stem-loop conﬁgurations also exhibited distinct
activity proﬁles. The “staggered” system failed to achieve an
adequate activity differential between the caged and uncaged
forms under any of the conditions we tested. As described above,
cMO 8a still exhibited gene-silencing activity in its caged form,
even though it successfully induced class-I phenotypes upon
photoactivation. The other “staggered” cMOs (8b-d) had lower
basal activities, but their uncaged forms failed to yield strong
ntla mutant phenotypes. In contrast, the “blunt” stem-loop
design provided greater caging efﬁciency, and two cMOs, 8e
and 8f, exhibited dynamic ranges appropriate for conditional
gene silencing: these two reagents did not induce mutant
phenotypes in their caged forms, and photoactivation of the
cMOs yielded fully penetrant phenotypes in most embryos.
Since our linker-1-based ntla cMO utilized the same inhibitory
oligomer as the “staggered” reagent 8a,
7 these results underscore
the importance of matching linker and stem-loop structures
for optimum cMO activity.
To better understand how cMO structure dictates in vivo
activity, we characterized the biophysical properties of each
reagent. We ﬁrst determined the binding energies for the ntla
MO/RNA duplex, each ntla MO/inhibitor heterodimer, and
various stem-loop structures. Thermal denaturation curves for
the ntla MO/RNA duplex and ntla MO/inhibitor heterodimers
were acquired by mixing the ntla-targeting MO with the
complementary oligomers in a 1:1 ratio and measuring their
temperature-dependent changes in hypochromicity at 260 nm
(Figure 5 and Tables 1-3). For these studies, we used the
commercially available amine-functionalized ntla-targeting and
Figure 4. Activity proﬁles of ntla cMOs with different structures. The leftmost panels show schematic representations of “staggered” (top) and “blunt”
(bottom) cMO conﬁgurations (n ) number of bases), and the other panels are distributions of phenotypes for each cMO conﬁguration 8a-h (see Table 1
and Figure 3) at a dose of 230 fmol/embryo.
Table 1. Oligomer sequences
oligomer sequence cMO
ntla MO
a GACTTGAGGCAGACATATTTCCGAT 8a-h, 8a′,
8e′ 22a-b
heg MO
a GTAATCGTACTTGCAGCAGGTGACA 9a-c
ﬂh MO
a GGGAATCTGCATGGCGTCTGTTTAG 10
etV2 MO
a CACTGAGTCCTTATTTCACTATATC 11
spt MO
a GCTTGAGGTCTCTGATAGCCTGCAT 12
ntla 10-mer TATGTCTGCC 8a, 8a′
“Staggered”
b
ntla 12-mer TATGTCTGCCTC 8b
“Staggered”
b
ntla 14-mer TATGTCTGCCTCAA 8c
“Staggered”
b
ntla 16-mer TATGTCTGCCTCAAGT 8d
“Staggered”
b
ntla 10-mer GCCTCAAGTC 8e, 8e′
“Blunt”
b
ntla 12-mer CTGCCTCAAGTC 8f
“Blunt”
b
ntla 14-mer GTCTGCCTCAAGTC 8g
“Blunt”
b
ntla 16-mer ATGTCTGCCTCAAGTC 8h
“Blunt”
b
heg 13-mer CAAGTACGATTAC 9a
“Blunt”
b
heg 11-mer GCTGCAAGTAC 9b
“Staggered”
b
heg 10-mer GTACGATTAC 9c
“Blunt”
b
ﬂh 10-mer GCAGATTCCC 10
“Blunt”
b
etV2 10-mer GGACTCAGTG 11
“Blunt”
b
spt 10-mer GACCTCAAGC 12
“Blunt”
b
ntla RNA
c ATCGGAAATATGTCTGCCTCAAGTC -
ﬂh RNA
c CTAAACAGACGCCATGCAGATTCCC -
heg RNA
c TGTCACCTGCTGCAAGTACGATTAC -
etV2 RNA
c GATATAGTGAAATAAGGACTCAGTG -
spt RNA
c ATGCAGGCTATCAGAGACCTCAAGC -
a MO oligomers for translational inhibition of targeted mRNA.
b Inhibitory MO oligomers for modulating cMO activity.
c RNA
oligomers for thermal denaturation studies.
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synthesis. The thermal denaturation curves were ﬁt to a two-
state oligomer binding model
31 to provide the corresponding
∆G values at 28 °C, the standard temperature for culturing
zebraﬁsh embryos. These analyses indicated that the binding
free energy for ntla MO and its complementary 25-base RNA
is -28.1 kcal/mol, while binding free energies for the various
ntla MO/inhibitor duplexes range from -10.7 to -16.2 kcal/
mol. The ∆G values for intermolecular ntla MO/inhibitor
complexes correlated with the length and sequence content of
the inhibitory MOs, independent of the region of complemen-
tarity (corresponding to “blunt” vs “staggered” hairpins). To
assess binding energies for ntla MO/inhibitor interactions within
an intramolecular stem-loop, we next conducted hypochro-
micity measurements of “blunt” and “staggered” ntla MO
hairpins. Since the 260-nm absorbance measurements would
photolyze the ntla cMOs (8a-h), we synthesized two ntla MO/
inhibitor hairpins (8a′ and 8e′) (Scheme 2) using the bifunctional
but nonphotolabile cross-linker 2b, which was prepared from
3-(methylamino)propan-1-ol (3b) in analogy to the DMNB-
based reagent 2a (Scheme 2). Derivation of the ∆G values from
these thermal denaturation curves using a hairpin-binding
model
31 revealed that the intramolecular binding free energies
of 8a′ and 8e′ were -4.9 and -6.9 kcal/mol, respectively (Table
4).
Taken together, these in vitro binding energies provide
qualitative insights into how cMOs perform in vivo. Intermo-
lecular ntla MO/inhibitor interactions with ∆G values lower than
-12 kcal/mol are required for low basal activities, and “blunt”
hairpins exhibit higher caging efﬁciencies than their “staggered”
counterparts because of their greater stabilization of the in-
tramolecular MO/inhibitor duplex (Table 2 and Figure 4).
Surprisingly, the ∆G values for the “blunt” and “staggered” ntla
MO/inhibitor duplexes correlate with the inhibitor length and
sequence in a similar manner, yet the activities of their
corresponding ntla cMOs upon photoactivation diverge. For
example, the intermolecular ntla MO/inhibitor duplexes derived
from “blunt” ntla cMOs 8e and 8f have ∆G values of -12.3
and -13.5 kcal/mol, respectively, and activated forms of these
cMOs produce strong ntla mutant phenotypes. The other two
“blunt” ntla cMOs (8g and 8h) have ∆G values of -15.5 and
-16.2 kcal/mol, respectively, and both induce only partial loss-
of-function phenotypes upon linker photolysis. An in vitro ntla
MO/inhibitor ∆G value between -12 and -14 kcal/mol
therefore represents the optimal balance of basal and induced
activities for the “blunt” ntla cMOs. However, the “staggered”
ntla MOs (8a and 8b) fail to induce full ntla mutant phenotypes
after uncaging, even though their corresponding ntla MO/
inhibitor duplexes have ∆G values of -10.7 and -13.3 kcal/
mol.
The molecular basis for these differing activities is unclear.
Our original solid-phase-chemistry-derived ntla MO
7 and the
“staggered” cMO 8a have identical targeting and inhibitory MO
sequences, suggesting that linker elements may contribute to
cMO activity after uncaging. In addition, the photolysis products
of ntla cMOs 8a and 8e are functionalized with linker substit-
uents that are not present in the oligomers used in our binding
energy measurements; the targeting MO liberated upon cMO
activation is 3′-functionalized with a 1,2,3-triazole and an
aliphatic amine, while the inhibitory oligomer is 5′-functional-
ized with an aliphatic chain and the DMNB-derived chro-
mophore. We therefore irradiated 8a and 8e with 360-nm light
and obtained thermal denaturation curves for the resulting ntla
MO/inhibitor heterodimers. Analysis of the photolysis products
by HPLC conﬁrmed that the two hairpin oligonucleotides are
uncaged with comparable efﬁcacies (∼75% conversion), and
the ∆G values for the resulting linker-functionalized ntla MO/
inhibitor complexes are similar to those observed for their
amine-functionalized counterparts (Figure S1 and Table S1 in
the Supporting Information). Since we were unable to discern (31) Marky, L. A.; Breslauer, K. J. Biopolymers 1987, 26, 1601–1620.
Figure 5. Representative thermal denaturation curves for MO duplexes
corresponding to ntla cMOs 8a-h (ntla-targeting and inhibitory MOs, 0.5
µM each) and noncleavable hairpins 8a′ and 8e′.
Table 2. Thermodynamic Parameters of MO/Inhibitor Dimers
Tm (°C)
b,e
oligomer
a observed predicted
c ∆G (kcal/mol)
d,e
8a 36.3 ( 0.4 38 -10.7( 0.2
8b 49.2 ( 1.3 46 -13.3( 0.3
8c 52.5 ( 1.5 49 -14.1( 0.2
8d 54.5 ( 0.9 57 -14.7( 0.1
8e 45.7 ( 0.6 42 -12.3( 0.3
8f 49.0 ( 0.8 49 -13.5( 0.3
8g 56.1 ( 0.6 57 -15.5( 0.2
8h 59.0 ( 0.7 61 -16.2( 0.4
9a 41.4 ( 1.6 44 -11.4( 0.2
9b 41.7 ( 2.3 44 -11.4( 0.5
9c 32.2 ( 1.1 34 -9.7( 0.1
10 43.7 ( 1.1 42 -12.5( 0.5
11 40.5 ( 1.1 42 -11.7( 0.3
12 42.9 ( 1.2 42 -11.9( 0.2
a Dimers of MO and inhibitory MO oligomers with 3′ and 5′ amine
modiﬁcations, respectively.
b Melting temperature of the MO/inhibitor
dimer.
c Predicted melting temperature according to eq 10, which is
based upon the Tm and ∆G values for 8a-h.
d Binding free energy of
the dimer at 28 °C.
e Tm and ∆G values were determined from
sigmoidal ﬁts of the thermal denaturation curves using the non-
self-complementary algorithm in MeltWin 3.0b software.
Table 3. Thermodynamic Parameters of MO/RNA Dimers
oligomer
a Tm (°C) ∆G (kcal/mol)
b
ntla 77.7 ( 0.8 -28.1 ( 2.4
heg 83.4 ( 0.9 -28.4 ( 2.2
ﬂh 83.4 ( 0.8 -27.5 ( 2.1
etV2 73.9 ( 1.0 -25.1 ( 2.8
spt 85.2 ( 1.2 -30.0 ( 3.2
a Dimers of 25-mer MO and RNA oligomers.
b Binding free energy
of the MO/RNA dimer at 28 °C.
Table 4. Thermodynamic Parameters of Noncleavable ntla MO
Hairpins
oligomer Tm (°C)
a,c ∆Ghairpin (kcal/mol)
b,c
8a′ 72.6 ( 2.0 -4.9 ( 0.6
8e′ 77.8 ( 0.9 -6.9 ( 0.5
a Melting temperature of the noncleavable MO hairpin.
b Binding free
energy of the hairpin at 28 °C.
c Tm and ∆Ghairpin values were
determined from sigmoidal ﬁts of the thermal denaturation curves using
the hairpin algorithm in MeltWin 3.0b software.
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inhibitor duplexes corresponding to 8a and 8e, we next
interrogated whether RNA strand exchange rates might account
for their divergent activities in vivo. We incubated each ntla
MO/inhibitor duplex with complementary 25-base RNA for
different lengths of time and resolved the resulting MO/RNA
duplexes by polyacrylamide gel electrophoresis (Figure S2 in
the Supporting Information). The RNA exchange rates for the
“staggered” and “blunt” MO/inhibitor duplexes were indistin-
guishable in this assay; MO/RNA hybridization was complete
in both cases within the time frame of RNA addition. Thus, the
activity differences between 8a and 8e cannot be explained by
in vitro MO/inhibitor thermodynamics or kinetics alone, and
the two cMOs might exhibit divergent photolysis, inhibitor
dissociation, or RNA exchange rates in vivo.
Modeling of cMO Activity in Vivo. While the correlation
between MO/inhibitor interaction strength and cMO activity
provides qualitative guidelines for reagent design, a quantitative
thermodynamic analysis is necessary to predict cMO efﬁcacy
with greater precision (Figure 6). Prior to photolysis, cMOs
adopt “open” and “closed” states according to the equilibrium
constant Khairpin (eq 1):
With the assumption that the total concentration of cMO prior
to uncaging ([cMO]t) signiﬁcantly exceeds that of its RNA target
([RNA]t), the basal level of RNA bound by the nonphotolyzed
cMO, given by ([cMOopen·RNA]/[RNA]t), can be described as
a function of [cMO]t, Khairpin, and the dissociation constant for
the MO/RNA duplex (Kd
MO·RNA) (eq 2):
Upon photoactivation, the fraction of RNA complexed with the
released targeting MO is a function of [cMO]t, Kd
MO·RNA, and
the dissociation constant for the MO/inhibitor complex (Kd
MO·INH)
(eqs 3 and 4):
Setting [cMO]t to a value of 4.6 µM, which approximates the
embryonic concentration of the ntla cMO (230 fmol/embryo,
50 nL embryonic volume at 5 hpf), and using our ntla cMO 8e
data to establish ∆G values of -28.1, -12.3, and -6.9 kcal/
mol for the MO/RNA duplex, intermolecular MO/inhibitor
duplex, and intramolecular MO/inhibitor hairpin, respectively,
led to the prediction that essentially all of the ntla RNA is MO-
complexed before and after cMO photolysis. This conclusion
clearly deviates from the phenotypes we observed with ntla cMO
8e-injected embryos.
Since these predictions do not take into account the complex-
ity of MO and RNA interactions in live organisms, we sought
to empirically derive the activity proﬁles of MOs in vivo. We
ﬁrst investigated whether the relationship between ntla RNA
activity and total ntla MO concentration can still be described
as a two-state equilibrium, even though the apparent equilibrium
constant for in vivo MO/RNA interactions (Kapp
MO·RNA, analogous
to Kd
MO·RNA in Figure 6) would include contributions from
oligonucleotide-binding proteins, RNA secondary structure, and
other embryonic factors. We injected the targeting MO into one-
cell-stage zebraﬁsh at doses of 0, 14, 28, 57, and 115 fmol/
embryo (approximate ﬁnal concentrations of 0, 0.28, 0.56, 1.1,
and 2.3 µM, respectively), lysed the embryos at 10 hpf, and
then detected the Ntla protein by quantitative immunoblotting
(Figure 7A). The ntla MO reduced the Ntla protein levels in a
dose-dependent manner that can be modeled as two-state
thermodynamic interaction, with the fraction of wild-type RNA
activity remaining in MO-injected embryos (RNAMO
Act/RNAWT
Act)
described as a function of total MO concentration ([MO]t) and
Kapp
MO·RNA (Figure 7B and eq 5):
Through this analysis, an apparent free-energy value (∆Gapp
MO·RNA)
of -8.7 kcal/mol for embryonic ntla MO/RNA interactions was
obtained.
It is important to note that this ∆Gapp
MO·RNA value does not
reﬂect the actual binding constant for the ntla MO/RNA duplex
in zebraﬁsh embryos but instead is an aggregate descriptor of
MO/RNA afﬁnity, RNA accessibility, MO/protein interactions,
and the inﬂuence of other embryonic factors on MO efﬁcacy.
Indeed, the 19.4 kcal/mol difference between ∆Gapp
MO·RNA and
the corresponding in vitro ∆G value underscores how signiﬁcant
these other variables can be. Our empirical data, however,
suggest that this thermodynamic description can have predictive
value, even though it does not explicitly consider MO and RNA
interactions with other cellular components or possible kinetic
contributions to in vivo function. Thus, MO-induced gene
silencing can be modeled in these simpliﬁed thermodynamic
terms.
To determine whether cMO activity can also be modeled in
simple thermodynamic terms, we next analyzed MO/inhibitor
interactions in vivo. We injected zebraﬁsh embryos with the
Figure 6. Schematic representation of cMO/RNA, MO/inhibitor (INH), and MO/RNA equilibria.
Khairpin )
[cMOopen]
[cMOclosed]
(1)
[cMOopen · RNA]
[RNA]t
)
[cMO]tKhairpin
[cMO]tKhairpin + KhairpinKd
MO·RNA + Kd
MO·RNA (2)
[MO] )
-Kd
MO·INH + √(Kd
MO·INH)
2 + 4Kd
MO·INH[cMO]t
2
(3)
[MO · RNA]
[RNA]t
) [MO]
Kd
MO·RNA + [MO]
(4)
RNAMO
Act
RNAWT
Act )
Kapp
MO·RNA
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MO·RNA + [MO]t
(5)
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the 14-base inhibitor corresponding to ntla cMO 8g (0, 150,
450, and 1350 fmol/embryo; ∼0, 3, 9, and 27 µM, respectively).
The resulting Ntla protein levels at 10 hpf were then quantiﬁed
as before (Figure 7C). The inhibitory oligomer repressed the
ntla MO activity in a concentration-dependent manner that can
be modeled as a three-state, competitive equilibrium involving
MO, inhibitor, and RNA interactions (Figure 7D). The fraction
of wild-type RNA activity associated with each MO and
inhibitor dose, RNAMO,INH
Act /RNAWT
Act, can be expressed as a
function of the apparent equilibrium constant for MO/inhibitor
interactions (Kapp
MO·INH; analogous to Kd
MO·INH in Figure 6), the
total concentration of the inhibitory oligomer ([INH]t), and
[MO]t (eqs 6 and 7):
Through this analysis, we derived an apparent ∆Gapp
MO·INH value
of -7.3 kcal/mol for 8g MO/inhibitor interactions. As with the
∆Gapp
MO·RNA value we determined for MO-dependent ntla silenc-
ing, this apparent free-energy value does not reﬂect the actual
binding constant for the ntla MO/inhibitor duplex in vivo but
instead integrates other interactions between these synthetic
oligonucleotides and cellular components. Since the 8.2 kcal/
mol difference between ∆Gapp
MO·INH and the corresponding in vitro
∆G value is signiﬁcantly smaller than the 19.4 kcal/mol
difference we observed for MO/RNA interactions (see Table 3
and Figure 7B), cellular factors appear to impact RNA activity
to a greater extent than MO function.
To assess the validity of modeling in vivo MO, RNA, and
inhibitor interactions in these simpliﬁed terms, we investigated
whether the apparent ∆Gapp
MO·RNA and ∆Gapp
MO·INH values can be
used to predict how cMO gene-silencing activity will be
inﬂuenced by changes in inhibitor structure. As discussed above,
the fraction of total RNA activity inhibited by a complementary
MO and the mitigating inﬂuence of an inhibitory oligomer can
be described by eqs 5-7. In the case of a cMO, [MO]t and
[INH]t will be equal after photoactivation, and the fraction of
wild-type RNA activity remaining in the presence of photoac-
tivated cMO (RNAcMO
Act /RNAWT
Act) is therefore a function of
Kapp
MO·RNA, Kapp
MO·INH, and [cMO]t (eqs 8 and 9):
In the case of our ntla cMO experiments shown in Figure 4,
Kapp
MO·RNA and [cMO]t can be approximated as 0.48 µM
(∆Gapp
MO·RNA )- 8.7 kcal/mol) and 4.6 µM, respectively. If it is
assumed that “blunt” MO/inhibitor interactions generally exhibit
a 8.2 kcal/mol difference between ∆Gapp
MO·INH and the corre-
sponding in vitro ∆G, the Kapp
MO·INH values for MO/inhibitor
interactions associated with ntla cMOs 8e, 8f, 8g, and 8h can
be estimated as 1100, 140, 50, and 1.6 µM, respectively. Using
these parameters in the model described by eqs 8 and 9 leads
to the prediction that ntla cMOs 8e and 8f will be similar in
efﬁcacy to the conventional ntla MO, achieving at least a 90%
knockdown of Ntla protein expression levels (red lines in Figure
8A,B). In contrast, ntla cMOs 8g and 8h are predicted to exhibit
weaker efﬁcacies at the same embryonic dose, since the
inhibitory oligomer interacts more strongly with the targeting
MO (red lines in Figure 8C,D).
Figure 7. ntla MO/RNA and ntla MO/inhibitor interactions in vivo. (A)
Ntla protein knockdown in zebraﬁsh embryos injected at the one-cell stage
with various ntla MO doses. Ntla and  -actin levels at 10 hpf were detected
by immunoblotting and quantiﬁed. (B) These data can be modeled as a
two-state equilibrium (solid line), yielding an apparent free energy value
(∆Gapp
MO·RNA )- 8.7 kcal/mol) that describes MO/RNA interactions in live
embryos. (C) Ntla protein knockdown in embryos injected at the one-cell
stage with ntla MO (115 fmol/embryo) and various doses of the 14-base
inhibitory oligomer corresponding to ntla cMO 8g. Ntla and  -actin levels
at 10 hpf were detected by immunoblotting and quantiﬁed as above. (D)
Modeling of the 8g data in (C) as a three-state, competitive equilibrium
(solid line) yields an apparent free-energy value (∆Gapp
MO·INH )- 7.3 kcal/
mol) that describes 8g MO/inhibitor interactions in vivo. The graphical data
are means of triplicate samples with error bars representing the standard
deviations.
RNAMO,INH
Act
RNAWT
Act )
Kapp
MO·RNA
Kapp
MO·RNA + [MO]
(6)
[MO] ≈
-(Kapp
MO·INH - [MO]t + [INH]t) +
√(Kapp
MO·INH - [MO]t + [INH]t)
2 + 4Kapp
MO·INH[MO]t
2
(7)
RNAcMO
Act
RNAWT
Act )
Kapp
MO·RNA
Kapp
MO·RNA + [MO]
(8)
[MO] )
-Kapp
MO·INH + √(Kapp
MO·INH)
2 + 4Kapp
MO·INH[cMO]t
2
(9)
13262 J. AM. CHEM. SOC. 9 VOL. 131, NO. 37, 2009
ARTICLES Ouyang et al.Our observations in vivo match these predictions. Photoac-
tivated 8e and 8f yielded the strongest mutant phenotypes of
the ntla cMO conﬁgurations we tested. Moreover, the predicted
efﬁcacies of 8g and 8h are consistent with their photoinduced
phenotypes and the relationship between ntla RNA activity and
phenotypic class (compare Figures 3B, 4, 7A,B, and 8C,D),
especially considering that UV light penetrance and therefore
cMO uncaging efﬁciencies in vivo will be attenuated to some
degree. On the basis of our in vitro uncaging results (see Figure
S1 in the Supporting Information) and the observed phenotypes
for irradiated ntla cMO-injected embryos, we estimate that our
whole-organism irradiation procedure achieves cMO photoac-
tivation yields of 50-75%. Our model also predicts that cMO
efﬁcacy will be increasingly compromised as ∆Gapp
MO·RNA in-
creases (compare the blue and red lines in Figure 8, which
represent a 10-fold change in MO/RNA interaction strength),
since the concentration of photoactivated cMO required to
achieve a given level of RNA silencing increases in a manner
disproportionate to that of a conventional MO. This latter issue
is of particular importance because the MO doses required to
induce mutant phenotypes vary signiﬁcantly between genes,
reﬂecting different RNA activity thresholds for wild-type
physiology and variable RNA sequence accessibilities. In
addition, MO doses greater than 1000 fmol/embryo (∼20 µM)
are generally avoided to minimize cytotoxicity.
In contrast, the MO/inhibitor interaction strength associated
with optimum cMO efﬁcacy should not vary signiﬁcantly
between genes. The 25-base targeting MOs are typically
designed to avoid secondary structures, and they are not known
to interact in a sequence-speciﬁc manner with DNA- or RNA-
binding proteins. Rather, the binding free energies for the intra-
and intermolecular MO/inhibitor duplexes dictate the fraction
of targeting MO that is free to anneal to its RNA target, thereby
establishing the basal and photoinduced activities of a given
cMO. Our ﬁndings suggest that cMOs should have ∆Gapp
MO·INH
values of approximately -5 kcal/mol or greater for their
corresponding intermolecular MO/inhibitor duplexes, as this
interaction strength in vivo would allow efﬁcient gene-silencing
upon cMO photoactivation for a broad range of targeting MO
potencies. Maximizing the cMO activity in this manner,
however, is counterbalanced by the need to maintain the
“closed” cMO hairpin state prior to photoactivation. In fact,
the ∆Gapp
MO·INH value of -4.1 kcal/mol predicted for ntla cMO
8e may represent the optimum thermodynamic parameter for
cMO efﬁcacy. Further attenuation of the MO/inhibitor interac-
tion will eventually yield undesirable levels of basal activity,
and a small fraction of embryos injected with the ntla cMO 8e
exhibited weak mutant phenotypes without irradiation (see
Figure 4).
Guidelines for Hairpin cMO Design. Taken together, our
results demonstrate that cMO activity can be modeled as a
competitive three-state equilibrium, even though this approach
does not explicitly consider how MO activity and RNA
accessibility are inﬂuenced by cellular proteins, RNA structure,
and other embryonic factors. Moreover, this analysis does not
require the determination of actual MO/RNA or MO/inhibitor
binding afﬁnities in whole embryos. We therefore sought to
establish simple guidelines for the preparation of cMOs targeting
other genes and to empirically test their validity. Such design
criteria would signiﬁcantly advance the use of cMOs in chemical
Figure 8. Modeling of in vivo cMO activity. Photoactivated cMOs and MOs inhibit their RNA targets with different efﬁcacies, which diverge as the
MO/RNA interaction strength decreases. This divergent activity proﬁle is exacerbated when the MO/inhibitor interaction strength increases. RNA activity
curves for MOs and photoactivated cMOs associated with in vivo MO/RNA interaction energies of (red) -8.7 and (blue) -7.3 kcal/mol are shown for
intermolecular MO/inhibitor interaction energies estimated for the “blunt” ntla cMOs (A) 8e, (B) 8f, (C) 8g, and (D) 8h, assuming complete uncaging upon
irradiation. Actual photoactivation yields in vivo are likely 50-75% (see text). Photoactivated cMO and conventional MO activity proﬁles are drawn as solid
and dashed colored lines, respectively. The embryonic ntla cMO concentration used in our structure-activity studies (see Figure 4) is indicated in each panel
by the vertical black line.
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ﬁnancial and time investments associated with these studies.
The disparate efﬁcacies of the two stem-loop structures indicate
that “blunt” cMO hairpins are preferable to “staggered”
conﬁgurations, and within our series of “blunt” ntla cMOs 8e-h,
in vitro MO/inhibitor ∆G values between -12 and -14 kcal/
mol yield an optimum balance between caged and uncaged
activities. Our modeling of cMO activity in vivo further suggests
that the higher MO/inhibitor ∆G value associated with ntla cMO
8e should be preferred, since it would maximize the inducible
gene-silencing activity over a broader range of targeting MO
efﬁcacies. This binding energy corresponds to a duplex melting
temperature of ∼45 °C (see Figure 5 and Table 2).
To facilitate the design of thermodynamically equivalent
cMOs against other genes, we ﬁrst determined the relationship
between MO duplex sequence and thermal stability. By multiple-
regression analysis of the ntla MO/inhibitor pairs listed in Table
2, we determined that the melting temperature of MO duplexes
(Tm
MO,i n°C) is correlated with sequence content according to
eq 10 and can be empirically related to its in vitro ∆G value
(in kcal/mol at 28 °C) by eq 11:
In eq 10, each nj (j ) A, T, G, C) is the number of times the
corresponding base appears in the MO sequence. Using this
equation, one can identify an appropriate inhibitor for a given
targeting MO, which ideally would generate a “blunt” hairpin
and have a predicted duplex melting temperature between 40
and 45 °C. This empirically derived algorithm should be most
accurate with MO duplexes similar in length to those in this
study, since it does not take into account the contribution of
nearest-neighbor effects.
We next tested the validity of our design criteria by targeting
four other zebraﬁsh genes: heg, ﬂh, etV2, and spadetail/tbx16
(spt). The transmembrane protein heg is expressed in the
endocardium during embryogenesis, mediating a signal that is
required for concentric growth of the heart.
24 Embryos lacking
heg function exhibit abnormally large heart chambers with walls
that are only one cell thick and therefore incapable of sustaining
blood circulation. These defects are apparent by 2 dpf and can
be recapitulated with the heg-targeting MO (5′-GTAATCG-
TACTTGCAGCAGGTGACA-3′) at doses of 230 fmol/embryo
(∼4.6 µM) or higher (79%, n ) 48). By 4 dpf, heg mutants
and morphants exhibit severe cardiac edema (Figure 9A). To
generate a heg cMO (9a), we conjugated the targeting MO to
an inhibitory oligomer 5′-CAAGTACGATTAC-3′ using linker
2a (Tables 1-3). We then injected wild-type zebraﬁsh embryos
with 9a at the one-cell stage (460 fmol/embryo; ∼9.2 µM) and
either irradiated the embryos with 360-nm light at 2 hpf or
cultured them in the dark. By 4 dpf, the irradiated embryos had
no blood circulation and exhibited cardiac edema (86%, n )
21), while the nonirradiated zebraﬁsh had normal cardiac
patterning and function (98%, n ) 44) (Figure 9B,C and Figure
S3 in the Supporting Information). To further test the predictive
value of our cMO design criteria, we evaluated two additional
heg cMOs: one contained a “staggered” inhibitor (9b; inhibitor
sequence 5′-GCTGCAAGTAC-3) with an intermolecular MO/
inhibitor ∆G value comparable to that for 9a, and the other
contained a shorter “blunt” inhibitor (9c; inhibitor sequence 5′-
GTACGATTAC-3′) with a weaker MO/inhibitor interaction
strength (Tables 1 and 2). In comparison to 9a, these alternative
heg cMOs were less effective in vivo. The majority of zebraﬁsh
embryos injected with an equivalent dose of either 9b or 9c
exhibited heg mutant phenotypes in the absence of irradiation
(9b: 66%, n ) 53; 9c: 62%, n ) 45), indicating that these
structural conﬁgurations do not adequately cage the MO activity
(Figure S3). Thus, the design parameters established through
our ntla cMO structure-activity relationship studies are trans-
ferable to other genes.
The ﬂh homeobox transcription factor is coexpressed with
ntla in the zebraﬁsh mesoderm, and loss of ﬂh expression also
causes ablation of the notochord.
25,32 However, mesodermal
(32) Melby, A. E.; Kimelman, D.; Kimmel, C. B. DeV. Dyn. 1997, 209,
156–165.
Figure 9. Evaluation of heg, ﬂh, and spt cMO activities in vivo. (A) Embryos injected with a conventional heg MO recapitulate heg mutant phenotypes,
including enlarged heart chambers, no blood circulation, and cardiac edema. (B, C) Embryos injected with heg cMO 9a exhibit heg mutant phenotypes upon
photoactivation. (D) Embryos injected with a conventional ﬂh MO recapitulate ﬂh mutant phenotypes, including notochord ablation and somite fusion
through the trunk midline. (E, F) Embryos injected with ﬂh cMO 10 exhibit ﬂh mutant phenotypes upon photoactivation. (G) Embryos injected with a
conventional spt MO recapitulate spt mutant phenotypes, including a loss of trunk somitic tissue and mislocalized mesodermal progenitors in the posterior
(“spadetail” morphology). (H, I) Embryos injected with spt cMO 12 exhibit partial spt mutant phenotypes upon photoactivation. Nonspeciﬁc toxicity is also
observed (data not shown). Developmental stages: (A-C) 4 dpf; (D-F, G-I) 1 dpf. Scale bars: (A-C) 400 µm; (D-F, G-I) 200 µm.
Tm
MO ) 1.9(nA + nT) + 5.7(nG + nC) (10)
∆G )- 0.25Tm
MO - 1.4 (11)
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transform into medial ﬂoor plate cells in ﬂh mutants; rather,
these populations differentiate into ectopic muscle to create fused
somites. Since no ﬂh-targeting MO had yet been described, we
ﬁrst identiﬁed a ﬂh-blocking oligonucleotide (5′-GGGAATCT-
GCATGGCGTCTGTTTAG-3′) and demonstrated its efﬁcacy
in zebraﬁsh embryos (Figure 9D). This antisense reagent is a
potent inhibitor of ﬂh function, and a dose of 60 fmol/embryo
(∼1.2 µM) is sufﬁcient to cause replacement of the notochord
with axial muscle cells in 1 dpf zebraﬁsh (89%, n ) 19). On
the basis of our cMO design criteria, we synthesized a hairpin
ﬂh cMO (10) using linker 2a a n da5 ′-GCAGATTCCC-3′
oligomer as the MO inhibitor (Tables 1-3). Wild-type zebraﬁsh
were injected at the one-cell stage with 10 at a dose of 100
fmol/embryo (∼2 µM) and either globally irradiated with 360-
nm light for 10 s at 2 hpf or cultured in the dark. As expected,
the majority of nonirradiated ﬂh cMO-injected embryos devel-
oped normally (89%, n ) 28), while the irradiated embryos
lacked a notochord and had fused somites (100%, n ) 11),
matching the mutant phenotype (Figure 9E,F).
The etV2 transcription factor is expressed in the lateral
mesoderm during early somitogenesis and then in vascular
endothelial cells of the axial, head, and intersomitic vessels.
26
It is believed that these early etV2-expressing cells are endot-
helial precursors, and etV2 mutants or embryos injected with
an etV2-blocking MO (5′-CACTGAGTCCTTATTTCAC-
TATATC-3′) exhibit disrupted blood-vessel formation and lack
circulation.
26 MO doses of 115 fmol/embryo (∼2.3 µM) or
higher are sufﬁcient to induce a fully penetrant mutant phenotype
(data not shown). We therefore synthesized a hairpin etV2 cMO
(11) containing a 5′-GGACTCAGTG-3′ inhibitory oligomer and
injected it into wild-type zebraﬁsh at the one-cell stage (230
fmol/embryo; ∼4.6 µM) (Tables 1-3). Embryos then irradiated
with 360 nm light for 10 s at 3 hpf had limited or no blood
circulation by 2.5 dpf (100%, n ) 12; see Supplementary Movie
1 in the Supporting Information), but most of the etV2 cMO-
injected embryos cultured in the dark exhibited normal blood
ﬂow (87%, n ) 15; see Supplementary Movie 2 in the
Supporting Information).
Finally, we designed and synthesized a cMO targeting spt,
which is another mesodermal T-box transcription factor.
21,33 The
ntla and spt genes are expressed in overlapping domains during
early embryogenesis and then become restricted to the axial
and paraxial mesoderm, respectively. Cells with ntla function
become the notochord, while the spt-expressing cells contribute
to the skeletal muscle in the ﬂanking somites. A loss of spt
function therefore causes a severe deﬁcit in trunk somitic
mesoderm as well as a gross mislocalization of the correspond-
ing progenitor cells to posterior regions (hence the “spadetail”
name). These phenotypes can be recapitulated with a spt-
targeting MO 12 (5′-GCTTGAGGTCTCTGATAGCCTGCAT-
3′)
34 at doses of 345 fmol/embryo (∼6.9 µM) or higher (61%,
n ) 23) (Figure 9G). As with the other cMOs described above,
we prepared the corresponding spt cMO hairpin using linker
2a and the inhibitory oligomer 5′-GACCTCAAGC-3′ (Tables
1-3). Wild-type embryos at the one-cell stage were injected
with 12, and a subset was globally irradiated with 360 nm light
for 10 s at 2 hpf. The majority of embryos cultured in the dark
developed normally (87%, n ) 24). Zebraﬁsh injected with a
dose of 700 fmol/embryo (∼14 µM) exhibited a loss of trunk
mesoderm but not posteriorly mislocalized progenitor cells upon
cMO photoactivation (31%, n ) 16) and also showed nonspe-
ciﬁc developmental defects due to general MO toxicity (62%,
n ) 16) (Figure 9H,I). These phenotypes indicate that the
photoactivated spt cMO 12 is not able to fully recapitulate the
activity of the conventional MO and that this reagent also
exhibits greater nonspeciﬁc toxicity. Thus, although our design
criteria were successful for cMOs targeting ntla, heg, ﬂh, and
etV2, there can be unforeseen MO or inhibitor interactions with
embryonic factors that reduce cMO efﬁcacy in certain situations.
In the case of the spt cMO, one possibility is that a 700 fmol/
embryo dose of the 35-base reagent approaches the toxicity level
of a 1000 fmol/embryo dose of the conventional 25-base MO.
Development of a BHQ-Based cMO for Two-Photon
Activation. To conclude our studies, we investigated the ability
of our hairpin cMO design to incorporate other photocleavable
groups. While nitrobenzyl-based chromophores such as the
DMNB group in our ntla, ﬂh, heg, etV2, and spt cMOs have
been widely used in biological applications, the UV light
required for their photolysis is potentially damaging and difﬁcult
to restrict in three-dimensional space. Two-photon excitation
typically uses wavelengths greater than 700 nm and affords
greater spatial resolution, but the DMNB group and most other
caging moieties have small two-photon cross sections and are
therefore inefﬁciently cleaved under these conditions. Two
notable exceptions are the bromohydroxycoumarin (BHC)
23 and
bromohydroxyquinoline (BHQ)
27 groups. Since the low ﬂuo-
rescence of BHQ chromophores makes them particularly useful
for biological applications, we designed a BHQ-based bifunc-
tional cross-linker (13, Scheme 3) for the preparation of cMOs.
As with our DMNB-based linker 2a, this two-photon-sensitive
linker incorporates an N-hydroxysuccinimide ester and a
terminal alkyne to enable orthogonal coupling to appropriately
modiﬁed MO oligomers.
To synthesize linker 13, we ﬁrst prepared BHQ derivative
14 as previously described
27 and then protected its phenolic
hydroxyl group with a benzenesulfonyl moiety to give 15. The
2-methyl group of 15 was then oxidized with selenium dioxide,
and the resulting aldehyde 16 was allylated to give alcohol 17.
Oxidative cleavage of 17 yielded aldehyde 18,
35 which was
reductively aminated with aqueous methylamine in the presence
of NaBH(OAc)3 to give the amino alcohol intermediate 19.I n
analogy to Scheme 1, compound 19 was acylated to form the
amide 20, and 1,1′-carbonyldiimidazole-mediated coupling of
this product with 6-amino-N-(prop-2-ynyl)hexanamide afforded
carbamate 21. Phenol deprotection and ester saponiﬁcation of
21 were simultaneously accomplished with 0.2 M NaOH to give
an acid intermediate, which was re-esteriﬁed with N-hydroxy-
succinimide in the presence of 1-ethyl-3-(3′-dimethylamino-
propyl)carbodiimide to give the two-photon-sensitive linker 13.
The bifunctional linker was then used to assemble ﬂuorescein-
conjugated and nonﬂuorescent ntla cMOs (22a and 22b,
respectively; Chart 2) using the corresponding inhibitory oli-
gomers (23a and 23b), which are analogous to that in the
optimum DMNB-containing ntla cMO 8e (Figure 4 and Table
1). Since the BHQ group has not been used previously with
carbamates and other BHQ-caged compounds have not been
tested in cultured cells or live organisms, we ﬁrst determined
whether the BHQ carbamate is stable in vivo and can be
(33) Grifﬁn, K. J.; Amacher, S. L.; Kimmel, C. B.; Kimelman, D.
DeVelopment 1998, 125, 3379–3388.
(34) Bisgrove, B. W.; Snarr, B. S.; Emrazian, A.; Yost, H. J. DeV. Biol.
2005, 287, 274–288.
(35) Yu, W.; Mei, Y.; Kang, Y.; Hua, Z.; Jin, Z. Org. Lett. 2004, 6, 3217–
3219.
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type zebraﬁsh embryos at the one-cell stage (230 fmol/embryo)
and irradiated a subset of them with 360-nm light for 10 s at 3
hpf. The embryos were then cultured for another day and scored
according to the four phenotypic classes described above. As
we hoped, the BHQ-based ntla cMO exhibited activity es-
sentially identical to that of the DMNB-based reagent 8e;
embryos injected with this reagent developed normally when
cultured in the dark but displayed a ntla phenotype upon
irradiation (Figure S4 in the Supporting Information).
We then examined whether the BHQ-based ntla cMO 22b
could be activated in targeted regions of the zebraﬁsh embryo
using two-photon excitation. These experiments followed studies
conducted previously in our laboratory, in which we uncaged a
DMNB-based ntla cMO in a subset of mesodermal progenitor
cells, selectively inducing them to differentiate into medial ﬂoor
plate cells rather than the notochord.
7 To identify the irradiated
cells in this earlier investigation, we coinjected the zebraﬁsh
embryos with mRNA encoding Kaede ﬂuorescent protein, which
undergoes a green-to-red photoconversion upon one-photon
excitation. Because Kaede is inefﬁciently converted by two-
photon excitation, we utilized a caged coumarin ﬂuorophore
conjugated to dextran (dextran-HCC-NPE) as a cell-autono-
mous photoactivatable tracer (Figure S5 in the Supporting
Information). This new class of caged coumarins is highly
sensitive to two-photon irradiation,
36,37 and dextran-HCC-NPE
has demonstrated efﬁcacy in vivo.
38 We injected dextran-HCC-
NPE into one-cell-stage embryos with either the BHQ-based
(36) Dakin, K.; Li, W. H. Nat. Methods 2006, 3, 959.
(37) Zhao, Y.; Zheng, Q.; Dakin, K.; Xu, K.; Martinez, M. L.; Li, W. H.
J. Am. Chem. Soc. 2004, 126, 4653–4663.
Scheme 3. Synthesis of Bifunctional BHQ Linker 13
a
a Reagents and conditions: (a) benzenesulfonyl chloride, DIPEA, CH2Cl2, 97%; (b) SeO2, dioxane, 80 °C, 91%; (c) In powder, allyl bromide, NH4Cl(aq),
THF, 96%; (d) K2OsO4·2H2O, lutidine, dioxane, H2O, then NaIO4, 75%; (e) methylamine(aq), NaBH(OAc)3, MeOH, H2O, 81%; (f) methyl adipoyl chloride,
DIPEA, CH2Cl2, 59%; (g) carbonyldiimidazole, DMF then 6-amino-N-(prop-2-ynyl)hexanamide, DIPEA, DMF, 81%; (h) 0.2 M NaOH(aq), THF, MeOH,
82%; (i) N-hydroxysuccinimide, EDCI, DMF, 48%.
Chart 2. Schematic Representation of BHQ-Based ntla cMOs 22a and 22b and Their Corresponding Precursors 23a and 23b
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An 80 µm × 60 µm × 50 µm region of the posterior, axial
mesoderm at the end of gastrulation was then subjected to two-
photon irradiation for 2 min (Figure 10A-D). These cells
normally differentiate into vacuolated notochord cells by 1 dpf,
and the embryos injected with the coumarin tracer and BHQ-
functionalized ntla MO inhibitor 23b contained a cluster of blue-
ﬂuorescent notochord cells toward the end of the yolk extension
(Figure 10A,E). In contrast, embryos injected with both the
photoactivatable tracer and ntla cMO 22b exhibited medial ﬂoor
plate cells with blue ﬂuorescence and few, if any, ﬂuorescently
labeled notochord cells (Figure 10F). These observations conﬁrm
the sensitivity of the BHQ-based reagent to two-photon pho-
tolysis and illustrate the versatility of the hairpin cMO archi-
tecture.
Conclusion
Photoactivatable MOs are valuable probes of embryonic
patterning mechanisms, and their implementation by the devel-
opmental biology community will require efﬁcient synthetic
procedures and general principles for cMO design. To advance
these goals, we have devised a bifunctional linker for the
synthesis of hairpin cMOs that enables these probes to be
prepared in three steps from commercially available reagents.
This optimized synthetic procedure has enabled us to prepare
several ntla-targeting cMOs of differing conﬁgurations, and we
have used these structural variants to determine how the
thermodynamic properties of cMOs correlate with their in vivo
functions. Our studies reveal that hairpin cMO function is highly
dependent on the sequence and location of the complementary
inhibitor as well as the linker structure.
We further observed that MO/MO and MO/RNA binding free
energies in vitro differ dramatically from the apparent free
energies of their functional interactions in vivo, undoubtedly
reﬂecting the inﬂuence of oligonucleotide-binding proteins, RNA
secondary structure, and other embryonic factors. Although the
apparent free-energy values obtained through our in vivo studies
cannot accurately describe the true MO and RNA binding
afﬁnities in zebraﬁsh embryos, our ﬁndings demonstrate that
these thermodynamic descriptors can be used to predict MO
efﬁcacy. Thus, cMO activity in vivo can be modeled as a
competitive three-state equilibrium, and the complex interactions
between MOs and embryonic factors can be treated as an
aggregate phenomenon. Our ﬁndings establish a metric for cMO
design, which we have successfully applied to cMOs that target
the ﬂh, heg, and etV2 genes, and these empirically derived
principles will help guide future applications of cMOs in
functional genomic studies. Our insights should also be ap-
plicable to other caged hairpin reagents, including those based
upon ncPNAs and 2′-O-methyl RNAs.
22 Although these oligo-
nucleotide analogues interact with complementary oligomers
with distinct in vitro and in vivo free energy values, their design
and biological application are subject to the same principles
outlined in this study. As illustrated by the partial phenotypes
we observed with our spt cMO, however, the activity of caged
hairpin oligonucleotides can be attenuated in vivo through
mechanisms that are not yet understood. We anticipate that our
guidelines for cMO design will become more reﬁned as this
chemical technology is more broadly utilized in embryological
research.
Finally, the modularity of our hairpin cMOs provides an
opportunity for future improvements to this technology, as
illustrated by our development of a BHQ-based cMO that is
compatible with two-photon excitation. For example, linkers
that minimize the entropic loss associated with stem-loop
formation could increase the energetic difference between inter-
and intramolecular MO/inhibitor duplexes, thereby improving
the dynamic range of basal and photoinduced activities. Alterna-
tive approaches might involve incorporating the photocleavable
bond within the inhibitory oligomer or caging the MO with two
short complementary oligomers rather than one long inhibitor.
Investigating these possibilities through organic synthesis will
expand the utility of cMO technologies and help shed new light
on the molecular mechanisms of embryonic development.
Experimental Section
General Synthetic Procedures. All of the reactions were carried
out in ﬂame-dried glassware under an argon atmosphere using
commercial reagents without further puriﬁcation, unless otherwise
indicated. Reactions were magnetically stirred and monitored by
thin-layer chromatography (TLC) using glass-backed silica gel
60F254 (Merck, 250 µm thickness). Yields refer to chromatographi-
(38) Guo, Y. M.; Chen, S.; Shetty, P.; Zheng, G.; Lin, R.; Li, W. H. Nat.
Methods 2008, 8, 835–841.
Figure 10. Two-photon uncaging of the BHQ-based ntla cMO in vivo.
(A) Schematic representation of embryos injected with the dextran-HCC-
NPE photoactivatable tracer and then two-photon-irradiated within the
posterior axial mesoderm at the 10 hpf stage (red square, dorsal view). By
1 dpf, these irradiated cells normally differentiate into vacuolated notochord
cells (red rectangle, lateral view) toward the end of the yolk extension. (B)
IR gradient contrast image of the posterior axial mesoderm with the targeted
irradiation area indicated by the dashed red box (dorsal view). (C)
Fluorescent image of the same region prior to irradiation (excitation, 820
nm; emission, 525/70 nm). (D) Fluorescent image post-irradiation (same
conditions as in C). (E) Embryos injected with the dextran-HCC-NPE and
oligomer 23b contained a cluster of blue-ﬂuorescent notochord (nc) cells
by 1 dpf (lateral view; excitation, 436/20 nm; emission, 480/40 nm). (F)
Embryos injected with dextran-HCC-NPE and ntla cMO 22b exhibited
medial ﬂoor plate (mfp) cells with blue ﬂuorescence and few ﬂuorescently
labeled notochord cells (same conditions as in E). Scale bars: 50 µm.
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stated. SiO2 chromatography was carried out with EM Science silica
gel (60 Å, 70-230 mesh) as a stationary phase. 1H NMR and 13C
NMR spectra were acquired on Varian 300, 400, and 500 MHz
spectrometers and standardized to the NMR solvent peak. Elec-
trospray mass spectrometry (ESI-MS) was performed using a
Micromass ZQ single-quadrupole liquid chromatograph-mass
spectrometer (LC-MS) and a Micromass Q-TOF hybrid quadrupole
LC-MS. Detailed synthetic procedures and structural characteriza-
tion data are provided in the Supporting Information.
Representative Procedure for MO Inhibitor Synthesis (7e).
An MO oligomer (5′-GCCTCAAGTC-3′) with 5′-amine and 3′-
ﬂuorescein modiﬁcations was purchased from Gene-Tools, LLC
and used without further puriﬁcation. This oligomer (100 nmol)
was dissolved in borate buffer [0.1 M Na2B4O7 (pH 8.5), 100 µL]
and combined with linker 2a (0.76 mg, 1.5 µmol) in DMSO (15
µL). The reaction was shaken overnight in the dark and then
lyophilized to dryness. The resulting yellow gum was dissolved in
water (0.5 mL), washed three times with CHCl3 (0.5 mL), and
diluted to 1.5 mL with water. The yellow solution was loaded onto
Toyopearl Super-Q resin (400 µL), washed three times with wash
solution [aqueous 2.5 mM Na2B4O7 (pH 8.5), 50% acetonitrile
(ACN)] and two times with water. Fluoresceinated oligomers were
eluted from the resin with 600 µL of aqueous 5% HOAc/50% ACN,
washed three times with CHCl3 (0.6 mL), and neutralized with 10%
NH4OH(aq) (0.3 mL). Solvent was removed in vacuo, and the
remaining NH4OAc was removed by repeated aqueous solubiliza-
tion and lyophilization, affording 7e as a yellow solid (70 nmol,
70%). MS-ESI for 7e [M + H]+ (m/z): calcd for C184H264N69O61P10,
4728; found, 4728.
Representative Procedure for cMO Synthesis (8e). The
inhibitory oligomer 7e (50 nmol) and azide-functionalized ntla MO
7
6 (50 nmol) were dissolved in phosphate buffer [KH2PO4 (pH 8.0),
230 µL]. To this mixture was added sodium ascorbate (99.0 µg,
500 nmol) in 25 µL of water followed by TBTA (265 µg, 500
nmol) and CuI (95.2 µg, 500 nmol) in 50 µL of DMSO. The
reaction mixture was brieﬂy sonicated and then stirred overnight
at room temperature in the dark. Precipitate was removed from the
reaction mixture by centrifugation, and the supernatant was split
and desalted over two Zeba Desalt size-exclusion columns (Pierce)
according to the manufacturer’s instructions. The desired product
was puriﬁed from the reaction mixture by adjusting the solution
pH to 11.5 with 1 M NaOH(aq) and loading it onto a DNAPac
PA-100 ion-exchange HPLC column (Dionex, 9 mm × 250 mm).
Aqueous running buffers were (A) 0.02 M NaOH, 1% ACN and
(B) 0.375 M NaClO4 in 0.02 M NaOH and 1% ACN. A stepwise
gradient was used to separate the product and starting materials,
with speciﬁc conditions determined by column capacity. A repre-
sentative puriﬁcation gradient was the following: 7 to 19% B in 5
min, 19 to 22% B in 10 min, 22 to 50% B in 1 min, and 50% B for
9 min (ﬂow rate 4 mL/min). Elution fractions were collected with
the UV-vis ﬂow-cell lamp turned off to prevent photolysis.
Fractions (1 mL) were collected every 15 s and buffered with 1 M
NH4OAc(aq) (pH 5.0) (40 µL). The fractions containing ﬂuores-
ceinated product were combined and desalted over a Zeba size-
exclusion column. The eluent volume was reduced in vacuo to 50
µL, and the cMOs were precipitated with acetone (400 µL). After
centrifugation, the supernatant was discarded, and the cMO pellet
was washed with ACN (100 µL) and brieﬂy lyophilized, affording
8e as a yellow solid (7 nmol, 14%). MS-ESI for 8e [M + H]+
(m/z): calcd for C488H737N219O164P35, 13379; found, 13380.
Zebraﬁsh Aquaculture and Husbandry. Adult zebraﬁsh (wild-
type AB strain) were acquired from the Zebraﬁsh International
Resource Center. Embryos used in these studies were obtained by
natural matings and cultured in E3 embryo medium at 28.5 °C
according to standard procedures.
39
MO Microinjections. Various MO, MO/inhibitor duplex, and
cMO solutions containing 0.1% (w/v) phenol red were prepared
and microinjected at 1 or 2 nL/embryo. For example, to inject 115
fmol of MO, 2 nL of a 57.5 µM solution containing 0.1% (w/v)
phenol red was injected into each zebraﬁsh embryo at the one-cell
stage. All embryo injections were done according to standard
procedures, and the embryos were subsequently cultured in E3
medium at 28.5 °C. For two-photon experiments, solutions contain-
ing 1.25 mM dextran-HCC-NPE and 0.1% (w/v) phenol red with
or without 57.5 µM cMO 22b were injected at 2 nL/embryo.
Photolysis of cMOs in Vitro. Photolysis reactions were per-
formed by dissolving 1 nmol of cMO hairpin in water (2 µL) and
irradiating for 1 min using a Leica DM4500B compound micro-
scope equipped with an A4 ﬁlter cube (ex: 360 nm, 40 nm bandpass)
a n da2 0 × water-immersion objective (0.50 NA, 13 mW/cm2
intensity at 360 nm). Longer irradiation times did not improve
reaction yields. The solutions were then adjusted to pH 11.5 with
0.02 M NaOH and analyzed by HPLC using a DNAPac PA-200
ion-exchange column (Dionex, 4 mm × 250 mm). Aqueous running
buffers were (A) 0.02 M NaOH, 1% ACN and (B) 0.375 M NaClO4
in 0.02 M NaOH and 1% ACN. The HPLC gradient was 7 to 50%
B in 27 min at 1.2 mL/min.
Photoactivation of cMOs in Vivo. Zebraﬁsh embryos between
the 64- and 256-cell stages were arrayed in an agarose microin-
jection template. Mercury lamp light was focused onto the
individual embryos for 10 s using a Leica DM4500B compound
microscope equipped with an A4 ﬁltercube and a 20× water-
immersion objective. Embryos were oriented with the animal pole
facing the light source. Following photoactivation, embryos were
cultured in E3 medium at 28.5 °C.
Two-Photon Irradiation of cMOs. Two-photon cMO photo-
activation in zebraﬁsh embryos was performed on an upright two-
photon confocal microscope (Ultima XY, Prairie Technologies, Inc.,
Middleton, WI) equipped with two Ti:sapphire lasers (Mai Tai HP,
Spectra Physics, Mountain View, CA) and a 40× (0.8 NA) water-
immersion objective (LUMPlanFl/IR, Olympus America, Center
Valley, PA). The 820-nm illumination from the ﬁrst laser (10 mW
at the back focal plane of the objective) was used to collect two
initial images for each embryo: an epiﬂuorescence image (bandpass:
525 nm center, 70 nm fwhm) and an IR gradient contrast image
(820-nm illumination).
40 Using the gradient contrast image, an 80
µm × 60 µm × 50 µm region of interest (ROI) was selected for
photoactivation. The ROI was then illuminated for 2 min at 750
nm (65 mW at the back focal plane of the objective) with the second
laser. Following photoactivation, the embryo was reimaged with
820-nm illumination. Following two-photon irradiation, embryos
were cultured in E3 medium at 28.5 °C.
Bright-Field and Fluorescence Microscopy. Chorions were
manually removed from 1 dpf embryos, which were immobilized
in E3 medium containing 0.7% (w/v) low-melt agarose and 0.05%
(w/v) tricaine. Bright-ﬁeld images were obtained at 5× with a Leica
MZFLIII ﬂuorescence stereoscope equipped with a Leica DC300F
digital camera. Differential interference contrast images and time-
lapse movies were obtained with a Leica DM4500B ﬂuorescence
microscope equipped with a 10× (0.25 NA) objective and a
QImaging Retiga-SRV digital camera. Fluorescence images were
also obtained with this equipment and a CFP ﬁlterset (excitation,
436/20 nm; emission, 480/40 nm).
Determination of MO Duplex Binding Energies. For inter-
molecular MO duplexes, the complementary oligomers (0.5 µM,
1:1 molar ratio) in buffer [100 mM KCl, 20 mM HEPES, 10 mM
MgCl2, 0.1 mM EDTA (pH 7.0), 1 mL] were denatured at 95 °C
for 5 min. Thermal denaturation curves were obtained by monitoring
temperature-dependent changes in the absorbance of 260-nm light
using a Varian Cary 300 spectrophotometer (annealing at 0.5 °C/
min). The hypochromicity curves were ﬁtted to a sigmoidal
function, and thermodynamic parameters were calculated using the
(39) Zebraﬁsh: A Practical Approach; Nusslein-Volhard, C., Dahm, R.,
Eds.; Oxford University Press: New York, 2002; Vol. 261.
(40) Dodt, H.; Eder, M.; Frick, A.; Zieglgansberger, W. Science 1999, 286,
110–113.
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Binding free energies were calculated at 28 °C. For intermolecular
MO/RNA duplexes, the complementary MO and RNA oligomers
were used in a 2:1 molar ratio to minimize hypochromicity changes
due to RNA self-annealing. For intramolecular duplexes, thermo-
dynamic parameters were calculated using the hairpin algorithm
in MeltWin 3.0b software.
Western Blot Analysis. At bud stage (10 hpf), wild-type and
MO-injected embryos were dechorinated with Pronase (1 mg/mL)
for 10 min at 28 °C. The embryos were transferred to microcen-
trifuge tubes and homogenized with a pipet in TM1 buffer [180
µL/sample; 100 mM NaCl, 5 mM KCl, 5 mM HEPES (pH 7.0),
1% (w/v) PEG-20000] containing protease inhibitors [1 mM PMSF,
5 mg/mL complete Mini protease inhibitor cocktail, EDTA-free
(Roche)] to remove yolks. Following centrifugation (500g, 5 min,
4 °C), the TM1 solution was replaced, and the pelleted cells were
homogenized again with a pipet and recentrifuged. Eighteen
deyolked embryos from each set of experimental conditions were
vortexed in SDS-PAGE loading buffer [50 µL/sample; 100 mM
Tris-HCl (pH 6.8), 330 mM 2-mercaptoethanol, 4% (w/v) SDS,
20% (v/v) glycerol, 100 mM DTT], sonicated for 1 min, and heated
to 100 °C for 5 min. The lysates were resolved on a 4-12% Bis-
Tris gradient acrylamide gel (ﬁve embryos/lane) and blotted onto
nitrocellulose according to standard protocols. Anti-Ntla antibody
was used at a 1:2000 dilution in 1× phosphate-buffered saline
containing 0.1% (v/v) Tween 20 and 0.2% (w/v) I-Block (Roche).
The anti-Ntla antibody was then detected using a horseradish
peroxidase-conjugated anti-rabbit IgG antibodies (GE) at 1:10000
dilution and the SuperSignal West Dura Extended Duration
Substrate kit (Pierce) according to the manufacturer’s instructions.
The chemiluminescence from the membrane was digitally imaged
(ChemiDoc XRS, Biorad), and the band intensity was measured
with Quantity One 4.5 software. The nitrocellulose membranes were
then reprobed with mouse anti- -actin [sc-8432 (Santa Cruz
Biotechnology) at a 1:250 dilution or clone AC-15 (Sigma) at a
1:10000 dilution] and horseradish peroxidase-conjugated anti-mouse
IgG antibodies (GE) at 1:10000 dilution to normalize for loading
differences between lanes.
Gel-Shift Analysis of MO/Inhibitor Exchange with RNA.
Targeting and inhibitory oligomers corresponding to ntla cMOs
8a and 8e (5 µM, 1:1 molar ratio) in buffer [100 mM KCl, 20 mM
HEPES, 10 mM MgCl2, 0.1 mM EDTA (pH 7.0), 28 µL] were
denatured at 95 °C for 2 min and annealed by cooling to 28 °C
over 15 min. The complementary, 3′-ﬂuoresceinated 25-base RNA
(3 µM in the above buffer, 2 µL) was then added to the annealed
MO duplex solution to achieve a ﬁnal RNA concentration of 0.2
µM. The mixture of oligomers was incubated at 28 °C for either 1
or 10 min and then chilled to 4 °C on ice. The “0 min” sample was
prepared by adding the RNA to the annealed MO duplex solution
at 4 °C, and the MO/RNA duplex was prepared by heat denaturation
and annealing, as was done for the MO/inhibitor duplexes. All of
the samples were then immediately mixed with chilled loading dye
[6× stock: 60% glycerol, 0.1 M Tris-HCl, 90 mM boric acid, 1
mM EDTA, 0.9 mM xylene cyanol (pH 8.4)] and resolved on a
15% Tris-borate-EDTA acrylamide gel at 200 V for 20 min at 4
°C. After electrophoresis, the acrylamide gel was analyzed with a
GE Typhoon imager (488 nm excitation, 580 nm emission).
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